The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 878.00
Bid: 888.00
Ask: 902.00
Change: -22.00 (-2.44%)
Spread: 14.00 (1.577%)
Open: 882.00
High: 900.00
Low: 878.00
Prev. Close: 900.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Mortgage Advice Bureau Later Life

15 Sep 2020 07:00

RNS Number : 9618Y
Mortgage Advice Bureau(Holdings)PLC
15 September 2020
 

15 September 2020

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Group")

Launch of Mortgage Advice Bureau Later Life

 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1.L) is pleased to announce the launch of "Mortgage Advice Bureau Later Life" (or "MAB Later Life"), a new and exclusive strategic alliance with Key Group. This new alliance enables MAB to enter a specialist and growing market with a leading proposition both to advisers and to customers.

Key Group is a leading integrated later life lending business covering product manufacturing, advice and intermediary services including product sourcing tools, compliance and training. Key Group was formed over 21 years ago and has helped over-55s release more than £5 billion of equity from their properties by taking a holistic view of their personal circumstances to achieve the best outcome for them. Key Group will provide its market leading infrastructure and regulatory umbrella to MAB Later Life.

MAB Later Life comprises a panel of four lenders including more2Life (Key Group's lifetime mortgage lender). All lenders are members of the Equity Release Council ("ERC") and all products meet the ERC's standards.

The first phase of the strategic alliance involved the distribution of later life mortgage products through a small pilot group of existing specialist MAB advisers, all working under the MAB Later Life brand. MAB is now extending this new opportunity to firms currently outside of the Group that are looking for a best in class proposition to capitalise on their specialism in this sector.

This strategic alliance broadens MAB's addressable market in an important growth segment which is highly intermediated. Customers need comprehensive financial advice more than ever at this important point in their lives and advisers want to provide customers with a range of considerations and choices. This includes options to release equity in order to supplement often inadequate pension provision or provide inter-generational assistance to family members. It is estimated that the total value of secured and unsecured debt for over-55s will rise, from about £211 billion in 2020 to £300 billion in 2030(1). It is also estimated that the housing wealth of the over-55s is worth £2.5 trillion(2).

Commenting on the new launch, Ben Thompson, MAB's Deputy CEO, said:

"Broadening our addressable market to include products for the over 55s is an important part of our strategy, and a logical extension to our proposition. This exclusive strategic alliance provides MAB brokers with a greater range of products to enable them to compete at the highest level. Specialist advice is a key differentiator for intermediaries, and Later Life represents a clear opportunity for them to service new customers and extend their relationships with existing ones.

"Those over the age of 55 today typically have large amounts of potentially untapped wealth that if released could transform their retirement. Providing the right advice to customers has always been a cornerstone of MAB, and we are delighted to partner with Key Group to provide customers with help, reassurance, and advice on an important lifetime decision."

1 Centre for Economics and Business Research and more2life, 2020

2 Swiss Re Term and Health Watch 2017

For further information please contact:

Mortgage Advice Bureau (Holdings) plc

Tel: +44 (0) 1332 525007

Peter Brodnicki - Chief Executive Officer

Ben Thompson - Deputy Chief Executive Officer

Lucy Tilley - Chief Financial Officer

Numis Securities Limited (NOMAD and Broker)

Tel: +44 (0)20 7260 1000

Stephen Westgate / Hugo Rubinstein (Corporate Finance)

 

Media Enquiries:

investorrelations@mab.org.uk

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAKKQBPCBKDDCD
Date   Source Headline
28th Jul 20224:40 pmRNSSecond Price Monitoring Extn
28th Jul 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSTrading Update
14th Jul 20225:31 pmRNSDirector/PDMR Shareholding
14th Jul 20224:40 pmRNSSecond Price Monitoring Extn
14th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20227:00 amRNSCompletion of acquisition of The Fluent Money Grp
5th Jul 20227:00 amRNSAcquisition of The Fluent Money Group
30th Jun 20222:03 pmRNSDirectors' Shareholdings and PDMR notification
15th Jun 20225:29 pmRNSDirectors' Shareholdings and PDMR notification
10th Jun 20221:23 pmRNSBlock listing Interim Review
8th Jun 20225:47 pmRNSGrant of Options and PDMR Dealing
6th Jun 202212:36 pmRNSDirectors' Shareholdings and PDMR notification
25th May 20223:38 pmRNSResult of AGM
25th May 20227:00 amRNSAGM Statement
16th May 20226:15 pmRNSDirectors' Shareholdings and PDMR notification
29th Apr 20221:10 pmRNSDirectors' Shareholdings and PDMR notification
28th Apr 20228:53 amRNSHolding(s) in Company
25th Apr 20225:13 pmRNSPosting of Report and Accounts and Notice of AGM
20th Apr 202210:29 amRNSDirectors' Shareholdings and PDMR notification
4th Apr 20227:00 amRNSHolding(s) in Company
31st Mar 20224:53 pmRNSDirectors' Shareholdings and PDMR notification
29th Mar 20227:32 amRNSResults of Placing
28th Mar 20225:29 pmRNSProposed Equity Placing
28th Mar 20225:29 pmRNSAcquisition of The Fluent Money Group
28th Mar 20225:29 pmRNSFinal Results for the year ended 31 December 2021
18th Mar 20224:36 pmRNSPrice Monitoring Extension
17th Mar 20224:47 pmRNSHolding(s) in Company
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20224:19 pmRNSDirectors' Shareholdings and PDMR notification
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20224:20 pmRNSHolding(s) in Company
28th Feb 20223:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Feb 20224:06 pmRNSDirector/PDMR Shareholding
31st Jan 20222:19 pmRNSDirectors' Shareholdings and PDMR notification
27th Jan 20227:00 amRNSTrading Update
14th Jan 20223:51 pmRNSDirectors' Shareholdings and PDMR notification
6th Jan 20221:26 pmRNSDirectors' Shareholdings and PDMR notification
21st Dec 20218:54 amRNSHolding(s) in Company
15th Dec 20213:49 pmRNSDirectors' Shareholdings and PDMR notification
10th Dec 202112:00 pmRNSBlock listing Interim Review
8th Dec 20212:34 pmRNSHolding(s) in Company
30th Nov 20212:18 pmRNSDirectors' Shareholdings and PDMR notification
19th Nov 20215:37 pmRNSPDMR dealing
15th Nov 20213:36 pmRNSDirectors' Shareholdings and PDMR notification
1st Nov 20212:34 pmRNSDirectors' Shareholdings and PDMR notification
29th Oct 20212:18 pmRNSDirectors' Shareholdings and PDMR notification
26th Oct 20218:36 amRNSHolding(s) in Company
14th Oct 20214:43 pmRNSDirectors' Shareholdings and PDMR notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.